Top 5 High Tech Companies To Buy Right Now

Changyou.com (Nasdaq: CYOU  ) is expected to report Q2 earnings on July 29. Here's what Wall Street wants to see:

The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Changyou.com's revenues will increase 24.3% and EPS will expand 1.5%.

The average estimate for revenue is $183.1 million. On the bottom line, the average EPS estimate is $1.37.

Revenue details
Last quarter, Changyou.com booked revenue of $177.6 million. GAAP reported sales were 30% higher than the prior-year quarter's $136.8 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
Last quarter, non-GAAP EPS came in at $1.45. GAAP EPS of $1.46 for Q1 were 20% higher than the prior-year quarter's $1.22 per share.

Top 5 High Tech Companies To Buy Right Now: BG Medicine Inc.(BGMD)

BG Medicine, Inc., a life sciences company, engages in the discovery, development, and commercialization of diagnostic tests based on biomarkers in the United States. Its product pipeline includes BGM Galectin-3, a diagnostic test for heart failure that measures galectin-3 levels in blood plasma or serum; AMIPredict, a multivariate biomarker blood-based test for atherothrombotic cardiovascular disease; and LipidDx, a blood-based protein assay for the management of patients with lipid disorders. The company also offers TNF alpha blockers comprising Enbrel, Remicade and Humira, which are treatments indicated for autoimmune diseases, such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and Crohn?s disease. It has strategic collaborations and initiatives with pharmaceutical companies and other healthcare organizations, including Abbott Laboratories; ACS Biomarker B.V.; Humana Inc.; Merck & Co., Inc.; and Laboratory Corporation of America. The company was formerly known as Beyond Genomics, Inc. and changed its name to BG Medicine, Inc. in October 2004. BG Medicine, Inc. was founded in 2000 and is headquartered in Waltham, Massachusetts.

Top 5 High Tech Companies To Buy Right Now: Navidea Biopharmaceuticals Inc (NAVB.A)

Navidea Biopharmaceuticals, Inc. (Navidea), formerly Neoprobe Corporation, incorporated in 1983, is a biopharmaceutical company focused on the development and commercialization of precision diagnostic agents. As of December 31, 2011, the Company�� radiopharmaceutical development programs included Lymphoseek (Lymphoseek, Kit for the Preparation of Technetium Tc99m for Injection), a radiopharmaceutical agent for lymph node mapping; AZD4694, an imaging agent, and RIGScan, a tumor antigen-specific targeting agent. In January 2012, the Company executed an option agreement with Alseres Pharmaceuticals, Inc. (Alseres) to license [123I]-E-IACFT Injection, also called Altropane, an Iodine-123 radiolabeled imaging agent, being developed as an aid in the diagnosis of Parkinson�� disease, movement disorders and dementia. In August 2011, the Company sold its gamma detection device line of business (the GDS Business) to Devicor Medical Products, Inc.

Lymphoseek

< p>

Navidea�� pipeline includes clinical-stage radiopharmaceutical agents used to identify the presence and status of disease. Lymphoseek (Kit for the Preparation of Technetium Tc99m for Injection) is a lymph node targeting agent intended for use in intraoperative lymphatic mapping (ILM) procedures and lymphoscintigraphy employed in the overall diagnostic assessment of certain solid tumor cancers. The lymph system is a component of the body�� immune system. The key components of the lymph system are lymph nodes-small anatomic structures that contain disease-fighting lymphocytes, filter lymph of bacteria and cancer cells, and signal infection in response to heightened levels of pathogens. In Navidea�� Phase III clinical studies of Lymphoseek, it detected over 99% of positive nodes identified by vital blue dye (VBD). As of December 31, 2011, Navidea, in co-operation with UC, San Diego affiliate (UCSD), completed or initiated five Phase I clinical trials, one multi-c enter Phase II trial and three multi-center Phase II trial! s ! involving Lymphoseek. Two Phase III studies were completed in subjects with breast cancer and melanoma. During the year ended December 31, 2011, data from NEO3-09 were released, which indicated that all primary and secondary endpoints for the study were met. As of December 31, 2011, third Phase III clinical trial for Lymphoseek in subjects with head and neck squamous cell carcinoma (NEO3-06) was in progress.

AZD4694

AZD4694 is a Fluorine-18 labeled precision radiopharmaceutical candidate for use in the imaging and evaluation of patients with signs or symptoms of cognitive impairment such as Alzheimer's disease (AD). It binds to beta-amyloid deposits in the brain that can then be imaged in positron emission tomography (PET) scans. Amyloid plaque pathology is a required feature of AD and the presence of amyloid pathology is a supportive feature for diagnosis of probable AD. Patients who are negative for amyloid pathology do not have AD. AZD4694 has b een studied in several clinical trials. Clinical studies through Phase IIa have included more than 80 patients to date, both suspected AD patients and healthy volunteers. No significant adverse events have been observed. Results suggest that AZD4694 has the ability to image patients quickly and safely with high sensitivity.

RadioImmunoGuided Surgery

As of December 31, 2011, RIGScan had been studied in a number of clinical trials, including Phase III studies. Navidea has conducted two Phase III studies, NEO2-13 and NEO2-14, of RIGScan in patients with primary and metastatic colorectal cancer, respectively. Both studies were multi-institutional involving cancer treatment institutions in the United States, Israel, and the European Union.

The Company competes with Pharmalucence, Eli Lilly, Bayer Schering, General Electric and GE Healthcare.

Top Biotech Companies To Invest In 2014: Republic Bancorp Inc.(RBCAA)

Republic Bancorp, Inc. operates as the holding company for Republic Bank & Trust Company and Republic Bank, which provides banking, tax refund solutions, and mortgage banking services to individuals and businesses in the United States. The company offers a range of deposit products, including demand deposits, money market accounts, brokered and Internet money market accounts, savings deposits, individual retirement accounts, time deposits, and certificates of deposit. It also provides single family residential real estate loans; commercial loans; residential construction real estate loans; and consumer loans, which consists of home improvement and home equity loans, as well as secured and unsecured personal loans. In addition, the company offers private banking services; treasury management services, such as lockbox processing, remote deposit capture, business online banking, account reconciliation, and automated clearing house processing services; Internet banking service s and products through its Website, republicbank.com; and trust, title insurance, and other financial institution related products and services. Further, it provides tax refund solutions that include the payment of federal and state tax refunds through third party tax preparers. The company facilitates the payment of these tax refunds through refund anticipation loans, electronic refund checks, and electronic refund deposits. Its mortgage banking activities comprise origination and sale of loans in the secondary market, and the servicing of loans for others. As of December 31, 2009, the company had 44 banking centers, including 35 located in Kentucky; 5 located in metropolitan Tampa, Florida; 3 located in southern Indiana; and 1 located in metropolitan Cincinnati, Ohio. Republic Bancorp, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky.

Advisors' Opinion:

• [By Holly LaFon]

  In the fourth quarter, he bought 32 new stocks. The largest new buys are: Air Lease (AL), Colfax (CFX) and Republic Bancorp Inc. (RBCAA).

  Air Lease (AL)

Top 5 High Tech Companies To Buy Right Now: Ridgeline Energy Services Inc (RLE.V)

Ridgeline Energy Services Inc. operates as an energy services and water treatment technology company in Canada. The company is applying proprietary technology to treat water generated from industrial and commercial waste water markets. These markets include clients across various industries, including oil and gas. It offers proprietary waste water treatment and storage systems for the reuse and recycling of waste water, as well as for the recycle and reuse of commercial and industrial waste water, produced and hydraulic fracturing water, oil recovery water, chemical flood operations, and oil sands process water. The company also operates soil and wet waste treatment facilities that offer soil remediation and wet waste disposal services. In addition, it provides environmental site remediation and reclamation consulting services, including site remediation and reclamation, environmental assessments, drilling waste management, and environmental mapping to oil and gas producer s. Ridgeline Energy Services Inc. was founded in 1998 and is headquartered in Calgary, Canada.

Top 5 High Tech Companies To Buy Right Now: Pacrim Intl Cap Com Npv(PCN.TO)

Pacrim International Capital Inc., an investment holding company, engages in the rental of real estate properties. It also focuses on the production and sale of various packaging products. The company?s packaging products include paper boards, cartons, color boxes, and other paper products, as well as flexo series printed packages, offset series printed packages, paper pallet cardboard insert packages, slip sheets, and assembly display products. In addition, the company engages in the printing of trademarks. It offers its packaging materials primarily to the manufacturers of electronics, computers, machinery and equipment, non-perishable food products, toys, sport equipment, and various other products in China. The company was founded in 1990 and is headquartered in Hong Kong, Hong Kong.